>
Fa   |   Ar   |   En
   Serum lipid goal attainment in chronic kidney disease (CKD) patients under the Japan atherosclerosis society (JAS) 2012 guidelines  
   
نویسنده shimizu r. ,torii h. ,yasuda d. ,hiraoka y. ,kitada n. ,hashida t. ,yoshimoto a. ,kita t. ,kume n.
منبع journal of atherosclerosis and thrombosis - 2015 - دوره : 22 - شماره : 9 - صفحه:949 -957
چکیده    Aim: according to the japan atherosclerosis society 2012 guidelines (jas2012-gl),chronic kidney disease (ckd) has newly been added to the high-risk group in terms of atherosclerotic cardiovascular diseases. we therefore explored the lipid target level achievement rates under the jas2012-gl in real-world clinical practice. methods: we retrospectively reviewed the medical charts of patients who were hospitalized at the nephrology department at kobe city medical center general hospital in the period from april 1,2012 to may 31,2013 and explored the serum lipid target level achievement rates. patients without lipid data or those undergoing regular dialysis because of chronic renal failure were excluded. in this study,the ckd group (ckd-g) did not include ckd patients under secondary prevention for coronary heart disease (chd) or diabetes mellitus (dm). results: the ckd-g included 146 (81.1%) of the 180 enrolled patients. according to the jas2012- gl,100% of the ckd-g patients were categorized into the high-risk group,although only 12.1% of the ckd-g subjects were at high risk according to the jas2007-gl. under the jas2012-gl,the ldl cholesterol (ldl-c) and non-hdl cholesterol (non-hdl-c) target level achievement rates for ckd-g were 71.4% and 68.1%,respectively. according to the jas2007-gl,these rates were 81.3% and 79.1%,respectively,and,under both guidelines,these rates were 71.7% and 72.1% for primary prevention dm and 66.7% and 66.7% for chd,respectively. conclusions: after the revision of the jas-gl in 2012,the ldl-c and non-hdl-c target level achievement rates for ckd-g were reduced by approximately 10%; however,they remained similar to those for dm and higher than those for chd. © 2015,japan atherosclerosis society. all rights reserved.
کلیدواژه Chronic kidney disease; Guidelines; Lipoproteins; Risk stratification
آدرس division of clinical pharmacy,kobe gakuin university,kobe, Japan, division of clinical pharmacy,kobe gakuin university,kobe, Japan, division of clinical pharmacy,kobe gakuin university,kobe, Japan, division of clinical pharmacy,kobe gakuin university,kobe, Japan, department of pharmacy,kobe city medical center general hospital,kobe, Japan, department of pharmacy,kobe city medical center general hospital,kobe, Japan, department of nephrology,kobe city medical center general hospital,kobe, Japan, kobe city medical center general hospital,kobe, Japan, division of clinical pharmacy,kobe gakuin university,kobe, Japan
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved